{"transactions":[{"id":4638069,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-10-08T21:24:27.000Z","date":"2026-10-08","kind":"exercise","planned":true,"acquired":false,"shares":619,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3095,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":619},"source":{"system":"sec-edgar","filing":"0001225208-26-008338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2004380/000122520826008338/doc4.xml","form_type":"4"}},{"id":4638068,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-10-08T21:24:27.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":619,"price":85.65,"value":53017.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40033.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-008338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2004380/000122520826008338/doc4.xml","form_type":"4"}},{"id":4638067,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-10-08T21:24:27.000Z","date":"2026-10-08","kind":"exercise","planned":true,"acquired":true,"shares":619,"price":72.68,"value":44988.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40652.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-008338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2004380/000122520826008338/doc4.xml","form_type":"4"}},{"id":4616477,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-09-11T23:15:10.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":false,"shares":619,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3714,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":619},"source":{"system":"sec-edgar","filing":"0001225208-26-007774","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2004380/000122520826007774/doc4.xml","form_type":"4"}},{"id":4616476,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-09-11T23:15:10.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":619,"price":87.51,"value":54168.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40033.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-007774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2004380/000122520826007774/doc4.xml","form_type":"4"}},{"id":4616475,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-09-11T23:15:10.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":true,"shares":619,"price":72.68,"value":44988.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40652.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-007774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2004380/000122520826007774/doc4.xml","form_type":"4"}},{"id":691287,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-08-11T21:07:58.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":false,"shares":619,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4333,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":619},"source":{"system":"sec-edgar","filing":"0001225208-26-007065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007065/doc4.xml","form_type":"4"}},{"id":691286,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-08-11T21:07:58.000Z","date":"2026-08-11","kind":"sale","planned":true,"acquired":false,"shares":619,"price":92.03,"value":56966.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40033.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-007065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007065/doc4.xml","form_type":"4"}},{"id":691285,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-08-11T21:07:58.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":true,"shares":619,"price":72.68,"value":44988.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40652.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-007065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007065/doc4.xml","form_type":"4"}},{"id":711471,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-07-10T21:04:11.000Z","date":"2026-07-10","kind":"exercise","planned":true,"acquired":false,"shares":619,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4952,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":619},"source":{"system":"sec-edgar","filing":"0001225208-26-006576","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006576/doc4.xml","form_type":"4"}},{"id":711470,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-07-10T21:04:11.000Z","date":"2026-07-10","kind":"sale","planned":true,"acquired":false,"shares":619,"price":91.7,"value":56762.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40033.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-006576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006576/doc4.xml","form_type":"4"}},{"id":711469,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-07-10T21:04:11.000Z","date":"2026-07-10","kind":"exercise","planned":true,"acquired":true,"shares":619,"price":72.68,"value":44988.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40652.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-006576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006576/doc4.xml","form_type":"4"}},{"id":713947,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-07-07T22:56:18.000Z","date":"2026-07-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":377,"price":95.18,"value":35882.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e)."}],"balance_after":40033.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-006535","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006535/doc4.xml","form_type":"4"}},{"id":723189,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-07-01T00:01:07.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":false,"shares":619,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5571,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":619},"source":{"system":"sec-edgar","filing":"0001225208-26-006263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006263/doc4.xml","form_type":"4"}},{"id":723188,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-07-01T00:01:07.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":619,"price":91.4002,"value":56576.7238,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $91.185 to $91.650. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":40410.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-006263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006263/doc4.xml","form_type":"4"}},{"id":723187,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-07-01T00:01:07.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":true,"shares":619,"price":72.68,"value":44988.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":41029.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-006263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006263/doc4.xml","form_type":"4"}},{"id":775719,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-18T21:29:30.000Z","date":"2026-05-18","kind":"exercise","planned":true,"acquired":false,"shares":620,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6190,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":620},"source":{"system":"sec-edgar","filing":"0001225208-26-005464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005464/doc4.xml","form_type":"4"}},{"id":775718,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-18T21:29:30.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":620,"price":81.14,"value":50306.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40410.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-005464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005464/doc4.xml","form_type":"4"}},{"id":775717,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-18T21:29:30.000Z","date":"2026-05-18","kind":"exercise","planned":true,"acquired":true,"shares":620,"price":72.68,"value":45061.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":41030.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-005464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005464/doc4.xml","form_type":"4"}},{"id":785457,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:41.000Z","date":"2026-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":362,"price":79.96,"value":28945.52,"ownership":{"direct":true},"balance_after":40410.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-005130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005130/doc4.xml","form_type":"4"}},{"id":787478,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Performance Rights","published_at":"2026-05-09T01:16:31.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":7850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."}],"balance_after":7850,"derivative":{"exercise_date":"2029-05-07","underlying":"Common Stock","underlying_shares":7850},"source":{"system":"sec-edgar","filing":"0001225208-26-005045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005045/doc4.xml","form_type":"4"}},{"id":787477,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-09T01:16:31.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":39900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":39900,"derivative":{"exercise_price":82.76,"exercise_date":"2027-05-07","expiration_date":"2033-05-06","underlying":"Common Stock","underlying_shares":39900},"source":{"system":"sec-edgar","filing":"0001225208-26-005045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005045/doc4.xml","form_type":"4"}},{"id":787476,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:31.000Z","date":"2026-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":450,"price":82.76,"value":37242.0,"ownership":{"direct":true},"balance_after":40772.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-005045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005045/doc4.xml","form_type":"4"}},{"id":787475,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:31.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":309,"price":83.2,"value":25708.8,"ownership":{"direct":true},"balance_after":41222.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-005045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005045/doc4.xml","form_type":"4"}},{"id":787474,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:31.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":7850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":41531.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-005045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005045/doc4.xml","form_type":"4"}},{"id":794464,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-04T23:30:46.000Z","date":"2026-05-04","kind":"exercise","planned":true,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001225208-26-004909","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004909/doc4.xml","form_type":"4"}},{"id":794463,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-04T23:30:46.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1019,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001225208-26-004909","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004909/doc4.xml","form_type":"4"}},{"id":794462,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-04T23:30:46.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":1019,"price":83.98,"value":85575.62,"ownership":{"direct":true},"balance_after":33681.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-004909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004909/doc4.xml","form_type":"4"}},{"id":794461,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-04T23:30:46.000Z","date":"2026-05-04","kind":"exercise","planned":true,"acquired":true,"shares":1019,"price":59.2567,"value":60382.5773,"ownership":{"direct":true},"balance_after":34700.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-004909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004909/doc4.xml","form_type":"4"}},{"id":794460,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-04T23:30:46.000Z","date":"2026-05-03","kind":"tax_withholding","planned":true,"acquired":false,"shares":252,"price":83.98,"value":21162.96,"ownership":{"direct":true},"balance_after":33681.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-004909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004909/doc4.xml","form_type":"4"}},{"id":794459,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-04T23:30:46.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":82.9889,"value":82988.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $82.540 to $83.490. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":33933.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-004909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004909/doc4.xml","form_type":"4"}},{"id":794458,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-04T23:30:46.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":19,"price":83.988,"value":1595.772,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $83.980 to $84.095. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":34933.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-004909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004909/doc4.xml","form_type":"4"}},{"id":794457,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-04T23:30:46.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":true,"shares":1019,"price":59.2567,"value":60382.5773,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025."}],"balance_after":34952.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-004909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004909/doc4.xml","form_type":"4"}},{"id":814850,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-04-07T00:42:22.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2038,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001225208-26-004422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004422/doc4.xml","form_type":"4"}},{"id":814849,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-04-07T00:42:22.000Z","date":"2026-04-06","kind":"sale","planned":true,"acquired":false,"shares":1019,"price":80.984,"value":82522.696,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $80.64 to $81.07. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":33933.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-004422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004422/doc4.xml","form_type":"4"}},{"id":814848,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-04-07T00:42:22.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":true,"shares":1019,"price":59.2567,"value":60382.5773,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025."}],"balance_after":34952.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-004422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004422/doc4.xml","form_type":"4"}},{"id":849417,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-03-11T21:10:00.000Z","date":"2026-03-11","kind":"exercise","planned":true,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3057,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001225208-26-003538","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826003538/doc4.xml","form_type":"4"}},{"id":849416,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-03-11T21:10:00.000Z","date":"2026-03-11","kind":"sale","planned":true,"acquired":false,"shares":1019,"price":85.3822,"value":87004.4618,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $85.16 to $85.76. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide,uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":33933.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-003538","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826003538/doc4.xml","form_type":"4"}},{"id":849415,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-03-11T21:10:00.000Z","date":"2026-03-11","kind":"exercise","planned":true,"acquired":true,"shares":1019,"price":59.2567,"value":60382.5773,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025."}],"balance_after":34952.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-003538","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826003538/doc4.xml","form_type":"4"}},{"id":888929,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-02-23T22:08:51.000Z","date":"2026-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":432,"price":79.78,"value":34464.96,"ownership":{"direct":true},"balance_after":33933.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-002409","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826002409/doc4.xml","form_type":"4"}},{"id":902025,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-02-17T22:16:02.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":198,"price":75.87,"value":15022.26,"ownership":{"direct":true},"balance_after":34365.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-001986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826001986/doc4.xml","form_type":"4"}},{"id":902024,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-02-17T22:16:02.000Z","date":"2026-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":258,"price":75.87,"value":19574.46,"ownership":{"direct":true},"balance_after":34563.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-001986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826001986/doc4.xml","form_type":"4"}},{"id":902023,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-02-17T22:16:02.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":12820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on February 12, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":34821.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-001986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826001986/doc4.xml","form_type":"4"}},{"id":942644,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-01-09T22:41:32.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4076,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001225208-26-000558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826000558/doc4.xml","form_type":"4"}},{"id":942643,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-01-09T22:41:32.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":1019,"price":85.7037,"value":87332.0703,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $85.45 to $85.95. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of theIssuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":22001.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-000558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826000558/doc4.xml","form_type":"4"}},{"id":942642,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-01-09T22:41:32.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":true,"shares":1019,"price":59.2567,"value":60382.5773,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025."}],"balance_after":23020.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-000558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826000558/doc4.xml","form_type":"4"}},{"id":971857,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-12-12T22:57:46.000Z","date":"2025-12-12","kind":"exercise","planned":true,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5095,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001225208-25-009934","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009934/doc4.xml","form_type":"4"}},{"id":971856,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-12-12T22:57:46.000Z","date":"2025-12-12","kind":"sale","planned":true,"acquired":false,"shares":1019,"price":84.0287,"value":85625.2453,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $83.58 to $84.46. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":22001.9103,"source":{"system":"sec-edgar","filing":"0001225208-25-009934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009934/doc4.xml","form_type":"4"}},{"id":971855,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-12-12T22:57:46.000Z","date":"2025-12-12","kind":"exercise","planned":true,"acquired":true,"shares":1019,"price":59.2567,"value":60382.5773,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025."}],"balance_after":23020.9103,"source":{"system":"sec-edgar","filing":"0001225208-25-009934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009934/doc4.xml","form_type":"4"}},{"id":1004203,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-11-10T23:06:02.000Z","date":"2025-11-10","kind":"exercise","planned":true,"acquired":false,"shares":1020,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6114,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":1020},"source":{"system":"sec-edgar","filing":"0001225208-25-009066","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009066/doc4.xml","form_type":"4"}},{"id":1004202,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-11-10T23:06:02.000Z","date":"2025-11-10","kind":"sale","planned":true,"acquired":false,"shares":1020,"price":82.5451,"value":84196.002,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $82.27 to $82.90. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":22001.9103,"source":{"system":"sec-edgar","filing":"0001225208-25-009066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009066/doc4.xml","form_type":"4"}},{"id":1004201,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-11-10T23:06:02.000Z","date":"2025-11-10","kind":"exercise","planned":true,"acquired":true,"shares":1020,"price":59.2567,"value":60441.834,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025."}],"balance_after":23021.9103,"source":{"system":"sec-edgar","filing":"0001225208-25-009066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009066/doc4.xml","form_type":"4"}},{"id":1080871,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-07-28T22:23:58.000Z","date":"2025-07-28","kind":"sale","planned":false,"acquired":false,"shares":4114,"price":79.4605,"value":326900.497,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $79.4500 to $79.4701. The price reported above reflects the weighted average sale price. The reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":22001.9103,"source":{"system":"sec-edgar","filing":"0001225208-25-006815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825006815/doc4.xml","form_type":"4"}},{"id":1091492,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-07-07T21:40:40.000Z","date":"2025-07-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":333,"price":76.79,"value":25571.07,"ownership":{"direct":true},"balance_after":26115.9103,"source":{"system":"sec-edgar","filing":"0001225208-25-006588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825006588/doc4.xml","form_type":"4"}},{"id":1152753,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-05-12T23:30:33.000Z","date":"2025-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":271,"price":73.68,"value":19967.28,"ownership":{"direct":true},"balance_after":26345.1066,"source":{"system":"sec-edgar","filing":"0001225208-25-004997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004997/doc4.xml","form_type":"4"}},{"id":1154329,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-05-09T23:35:19.000Z","date":"2025-05-09","kind":"exercise","planned":true,"acquired":false,"shares":330,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":330},"source":{"system":"sec-edgar","filing":"0001225208-25-004947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004947/doc4.xml","form_type":"4"}},{"id":1154328,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Performance Rights","published_at":"2025-05-09T23:35:19.000Z","date":"2025-05-08","kind":"grant","planned":true,"acquired":true,"shares":4225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":4225,"derivative":{"exercise_date":"2028-05-08","underlying":"Common Stock","underlying_shares":4225},"source":{"system":"sec-edgar","filing":"0001225208-25-004947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004947/doc4.xml","form_type":"4"}},{"id":1154327,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-05-09T23:35:19.000Z","date":"2025-05-08","kind":"grant","planned":true,"acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":21500,"derivative":{"exercise_price":74.63,"exercise_date":"2026-05-08","expiration_date":"2032-05-07","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001225208-25-004947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004947/doc4.xml","form_type":"4"}},{"id":1154326,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-05-09T23:35:19.000Z","date":"2025-05-09","kind":"sale","planned":true,"acquired":false,"shares":330,"price":74.4232,"value":24559.656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $74.135 to $74.735. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26616.1066,"source":{"system":"sec-edgar","filing":"0001225208-25-004947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004947/doc4.xml","form_type":"4"}},{"id":1154325,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-05-09T23:35:19.000Z","date":"2025-05-09","kind":"exercise","planned":true,"acquired":true,"shares":330,"price":45.2767,"value":14941.311,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":26946.1066,"source":{"system":"sec-edgar","filing":"0001225208-25-004947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004947/doc4.xml","form_type":"4"}},{"id":1154324,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-05-09T23:35:19.000Z","date":"2025-05-08","kind":"grant","planned":true,"acquired":true,"shares":4225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":26616.1066,"source":{"system":"sec-edgar","filing":"0001225208-25-004947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004947/doc4.xml","form_type":"4"}},{"id":1159956,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-05-05T23:30:33.000Z","date":"2025-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":247,"price":75.65,"value":18685.55,"ownership":{"direct":true},"balance_after":22391.1066,"source":{"system":"sec-edgar","filing":"0001225208-25-004769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004769/doc4.xml","form_type":"4"}},{"id":1159955,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-05-05T23:30:33.000Z","date":"2025-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":225,"price":75.65,"value":17021.25,"ownership":{"direct":true},"balance_after":22638.1066,"source":{"system":"sec-edgar","filing":"0001225208-25-004769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004769/doc4.xml","form_type":"4"}},{"id":1175987,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-04-08T21:12:04.000Z","date":"2025-04-08","kind":"exercise","planned":true,"acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":330,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001225208-25-004176","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004176/doc4.xml","form_type":"4"}},{"id":1175986,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-04-08T21:12:04.000Z","date":"2025-04-08","kind":"sale","planned":true,"acquired":false,"shares":300,"price":70.61,"value":21183.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":22863.1066,"source":{"system":"sec-edgar","filing":"0001225208-25-004176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004176/doc4.xml","form_type":"4"}},{"id":1175985,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-04-08T21:12:04.000Z","date":"2025-04-08","kind":"exercise","planned":true,"acquired":true,"shares":300,"price":45.2767,"value":13583.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":23163.1066,"source":{"system":"sec-edgar","filing":"0001225208-25-004176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004176/doc4.xml","form_type":"4"}},{"id":1215844,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-03-10T23:34:07.000Z","date":"2025-03-10","kind":"exercise","planned":true,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":630,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001225208-25-003194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003194/doc4.xml","form_type":"4"}},{"id":1215843,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-03-10T23:34:07.000Z","date":"2025-03-10","kind":"sale","planned":true,"acquired":false,"shares":400,"price":69.48,"value":27792.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":22588.0651,"source":{"system":"sec-edgar","filing":"0001225208-25-003194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003194/doc4.xml","form_type":"4"}},{"id":1215842,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-03-10T23:34:07.000Z","date":"2025-03-10","kind":"exercise","planned":true,"acquired":true,"shares":400,"price":45.2767,"value":18110.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":22988.0651,"source":{"system":"sec-edgar","filing":"0001225208-25-003194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003194/doc4.xml","form_type":"4"}},{"id":1264867,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-02-18T23:18:45.000Z","date":"2025-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":222,"price":76.19,"value":16914.18,"ownership":{"direct":true},"balance_after":22588.0651,"source":{"system":"sec-edgar","filing":"0001225208-25-001909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001909/doc4.xml","form_type":"4"}},{"id":1264866,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-02-18T23:18:45.000Z","date":"2025-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":165,"price":76.19,"value":12571.35,"ownership":{"direct":true},"balance_after":22810.0651,"source":{"system":"sec-edgar","filing":"0001225208-25-001909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001909/doc4.xml","form_type":"4"}},{"id":1264865,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-02-18T23:18:45.000Z","date":"2025-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":214,"price":76.19,"value":16304.66,"ownership":{"direct":true},"balance_after":22975.0651,"source":{"system":"sec-edgar","filing":"0001225208-25-001909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001909/doc4.xml","form_type":"4"}},{"id":1270145,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-02-13T23:04:15.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1030,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001225208-25-001710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001710/doc4.xml","form_type":"4"}},{"id":1270144,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-02-13T23:04:15.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":500,"price":76.34,"value":38170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":23189.0651,"source":{"system":"sec-edgar","filing":"0001225208-25-001710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001710/doc4.xml","form_type":"4"}},{"id":1270143,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-02-13T23:04:15.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":true,"shares":500,"price":45.2767,"value":22638.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":23689.0651,"source":{"system":"sec-edgar","filing":"0001225208-25-001710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001710/doc4.xml","form_type":"4"}},{"id":1301781,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-01-16T22:07:44.000Z","date":"2025-01-16","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1530,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001225208-25-000685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825000685/doc4.xml","form_type":"4"}},{"id":1301780,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-01-16T22:07:44.000Z","date":"2025-01-16","kind":"sale","planned":true,"acquired":false,"shares":500,"price":68.7643,"value":34382.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $68.42 to $69.07. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23189.0651,"source":{"system":"sec-edgar","filing":"0001225208-25-000685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825000685/doc4.xml","form_type":"4"}},{"id":1301779,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-01-16T22:07:44.000Z","date":"2025-01-16","kind":"exercise","planned":true,"acquired":true,"shares":500,"price":45.2767,"value":22638.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":23689.0651,"source":{"system":"sec-edgar","filing":"0001225208-25-000685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825000685/doc4.xml","form_type":"4"}},{"id":1331302,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-12-16T23:27:27.000Z","date":"2024-12-16","kind":"exercise","planned":true,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2030,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001225208-24-010858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824010858/doc4.xml","form_type":"4"}},{"id":1331301,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-12-16T23:27:27.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":74.0783,"value":185195.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $73.715 to $74.335. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23189.0651,"source":{"system":"sec-edgar","filing":"0001225208-24-010858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824010858/doc4.xml","form_type":"4"}},{"id":1331300,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-12-16T23:27:27.000Z","date":"2024-12-16","kind":"exercise","planned":true,"acquired":true,"shares":2500,"price":45.2767,"value":113191.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":25689.0651,"source":{"system":"sec-edgar","filing":"0001225208-24-010858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824010858/doc4.xml","form_type":"4"}},{"id":1456460,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-07-11T21:38:23.000Z","date":"2024-07-11","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4530,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001225208-24-007400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824007400/doc4.xml","form_type":"4"}},{"id":1456459,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-07-11T21:38:23.000Z","date":"2024-07-11","kind":"sale","planned":true,"acquired":false,"shares":500,"price":94.18,"value":47090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":23189.0651,"source":{"system":"sec-edgar","filing":"0001225208-24-007400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824007400/doc4.xml","form_type":"4"}},{"id":1456458,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-07-11T21:38:23.000Z","date":"2024-07-11","kind":"exercise","planned":true,"acquired":true,"shares":500,"price":45.2767,"value":22638.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":23689.0651,"source":{"system":"sec-edgar","filing":"0001225208-24-007400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824007400/doc4.xml","form_type":"4"}},{"id":1458477,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-07-08T22:26:45.000Z","date":"2024-07-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":410,"price":92.32,"value":37851.2,"ownership":{"direct":true},"balance_after":23189.0651,"source":{"system":"sec-edgar","filing":"0001225208-24-007360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824007360/doc4.xml","form_type":"4"}},{"id":1473810,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-06-20T21:44:13.000Z","date":"2024-06-20","kind":"exercise","planned":true,"acquired":false,"shares":535,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5030,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":535},"source":{"system":"sec-edgar","filing":"0001225208-24-006926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006926/doc4.xml","form_type":"4"}},{"id":1473809,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-06-20T21:44:13.000Z","date":"2024-06-20","kind":"sale","planned":true,"acquired":false,"shares":535,"price":90,"value":48150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":23512.7443,"source":{"system":"sec-edgar","filing":"0001225208-24-006926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006926/doc4.xml","form_type":"4"}},{"id":1473808,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-06-20T21:44:13.000Z","date":"2024-06-20","kind":"exercise","planned":true,"acquired":true,"shares":535,"price":45.2767,"value":24223.0345,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":24047.7443,"source":{"system":"sec-edgar","filing":"0001225208-24-006926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006926/doc4.xml","form_type":"4"}},{"id":1519595,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-05-13T21:46:59.000Z","date":"2024-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":377,"price":86.72,"value":32693.44,"ownership":{"direct":true},"balance_after":23512.7443,"source":{"system":"sec-edgar","filing":"0001225208-24-005983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005983/doc4.xml","form_type":"4"}},{"id":1522406,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Performance Rights","published_at":"2024-05-09T23:40:26.000Z","date":"2024-05-07","kind":"grant","planned":true,"acquired":true,"shares":2900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":2900,"derivative":{"exercise_date":"2027-05-07","underlying":"Common Stock","underlying_shares":2900},"source":{"system":"sec-edgar","filing":"0001225208-24-005890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005890/doc4.xml","form_type":"4"}},{"id":1522405,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-09T23:40:26.000Z","date":"2024-05-07","kind":"exercise","planned":true,"acquired":false,"shares":857,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":857},"source":{"system":"sec-edgar","filing":"0001225208-24-005890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005890/doc4.xml","form_type":"4"}},{"id":1522404,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-09T23:40:26.000Z","date":"2024-05-07","kind":"grant","planned":true,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":15500,"derivative":{"exercise_price":85.84,"exercise_date":"2025-05-07","expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001225208-24-005890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005890/doc4.xml","form_type":"4"}},{"id":1522403,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-05-09T23:40:26.000Z","date":"2024-05-07","kind":"sale","planned":true,"acquired":false,"shares":857,"price":85.6,"value":73359.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":23889.7443,"source":{"system":"sec-edgar","filing":"0001225208-24-005890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005890/doc4.xml","form_type":"4"}},{"id":1522402,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-05-09T23:40:26.000Z","date":"2024-05-07","kind":"tax_withholding","planned":true,"acquired":false,"shares":586,"price":85.09,"value":49862.74,"ownership":{"direct":true},"balance_after":24746.7443,"source":{"system":"sec-edgar","filing":"0001225208-24-005890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005890/doc4.xml","form_type":"4"}},{"id":1522401,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-05-09T23:40:26.000Z","date":"2024-05-07","kind":"exercise","planned":true,"acquired":true,"shares":857,"price":36.75,"value":31494.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023."}],"balance_after":25332.7443,"source":{"system":"sec-edgar","filing":"0001225208-24-005890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005890/doc4.xml","form_type":"4"}},{"id":1522400,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-05-09T23:40:26.000Z","date":"2024-05-07","kind":"grant","planned":true,"acquired":true,"shares":2900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":24475.7443,"source":{"system":"sec-edgar","filing":"0001225208-24-005890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005890/doc4.xml","form_type":"4"}},{"id":1522399,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-05-09T23:40:26.000Z","date":"2024-05-07","kind":"grant","planned":true,"acquired":true,"shares":4660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":21575.7443,"source":{"system":"sec-edgar","filing":"0001225208-24-005890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005890/doc4.xml","form_type":"4"}},{"id":1526676,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-05-06T23:18:09.000Z","date":"2024-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":291,"price":85.25,"value":24807.75,"ownership":{"direct":true},"balance_after":16915.7443,"source":{"system":"sec-edgar","filing":"0001225208-24-005704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005704/doc4.xml","form_type":"4"}},{"id":1526675,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2024-05-06T23:18:09.000Z","date":"2024-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":281,"price":85.06,"value":23901.86,"ownership":{"direct":true},"balance_after":17206.7443,"source":{"system":"sec-edgar","filing":"0001225208-24-005704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005704/doc4.xml","form_type":"4"}},{"id":1544815,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-04-09T21:33:36.000Z","date":"2024-04-09","kind":"exercise","planned":true,"acquired":false,"shares":857,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":857,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":857},"source":{"system":"sec-edgar","filing":"0001225208-24-005020","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005020/doc4.xml","form_type":"4"}}],"next_cursor":"2024-04-09T21:33:36.000000Z,1544815"}